Obstetrics News and Research

RSS

Gynecology and obstetrics are twin subjects that deal with the female reproductive system. While obstetrics deals with pregnancy and its associated procedures and complications, gynaecology involves treating women who are not pregnant.

Two pioneering hospital systems to pilot Unity Medical's Medical Video jLog for Apple iPad

Unity Medical, Inc. a premier provider of digital health tools that enhance the patient experience today announced that two pioneering hospital systems will pilot the company's new Medical Video jLog™ for the Apple iPad™, an innovative application that utilizes short form interactive video to explain common medical procedures such as CT scans, cardiac stent placements, and physical rehabilitation treatment.

6 Apr 2010

NPCs as effective as doctors in performing Caesarean sections

Every year, some 7.5 million mothers and new-borns die during pregnancy or childbirth, almost all of whom are in low and middle-income countries. One reason for this is the lack of trained medical staff, particularly doctors. A doctoral thesis from Karolinska Institutet now shows that a solution could be the training of nurses in caesarean sections and other life-saving surgery.

3 Apr 2010

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, today announced that it has signed a co-promotion agreement for Zipsor™ (diclofenac potassium) Liquid Filled Capsules with Ferring Pharmaceuticals Inc., a global bio-pharmaceutical company, headquartered in Switzerland.

1 Apr 2010

SEE BABY opens spa-like facility in mid-town Atlanta to provide low-cost medical care

In an economy where soaring healthcare costs and poor medical care seem to go hand in hand, SEE BABY has opened a beautiful spa-like facility in mid-town Atlanta staffed with well-trained, experienced personnel who provide the best in medical care for a cost up to 70% lower than nearby competitors.

31 Mar 2010

Study evaluates OCP treatment to prevent endometrioma recurrence

Ovarian endometriomas, better known as ovarian 'chocolate' cysts for the brown liquid they contain, can be easily removed by surgery. However, recurrence is common, which can cause ongoing pain and complications. A study evaluated for Faculty of 1000 suggests a simple and effective remedy - the oral contraceptive pill.

31 Mar 2010

Facts and treatment options for endometriosis

One out of every two women struggling to conceive may suffer from endometriosis - the leading cause of infertility - according to research from Camran Nezhat, M.D., gynecologist at El Camino Hospital, the hospital of the Silicon Valley.

31 Mar 2010

ASA encourages spreading awareness about Doctors Day 2010

The American Society of Anesthesiologists joins communities across the United States today to recognize Doctors Day 2010, a day with a special tie to anesthesiology.

30 Mar 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

29 Mar 2010

Evaluating potential of Ampligen and TLR3 agonists as cancer immunotherapeutics

Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.

26 Mar 2010

New CONSORT statement to improve reporting of trial findings published

New guidance to improve the reporting of trial findings is published simultaneously today (24 March 2010) by PLoS Medicine and eight other leading journals around the world, BMJ, The Lancet, Obstetrics & Gynecology, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.

26 Mar 2010

Pregnant breast cancer patients can receive chemotherapy without endangering baby health

Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).

26 Mar 2010

Clinicians can help pregnant women in making lifestyle changes for healthy weight gain

A new study from UCSF shows that prenatal health care professionals are concerned about patients' excessive weight gain during pregnancy but have difficulty providing effective counseling.

24 Mar 2010

New provision in health care bill ensures physicians’ participation in PQRI program

A provision in the health care reform measure passed by the House of Representatives Sunday and signed into law today by President Barack Obama includes participation in the American Board of Medical Specialties Maintenance of Certification® (ABMS MOC®) as an option for the nation’s physicians to fulfill requirements of the Centers for Medicare and Medicaid Services (CMS) Physician Quality Reporting Initiative (PQRI

24 Mar 2010

HPV test could help predict risk of cervical cancer, but more research needed

Testing for the human papillomavirus (HPV) - the major cause of cervical cancer - may not help to identify women who are at risk of the disease, a new UK study suggests.

24 Mar 2010

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.

22 Mar 2010

Women need education on risks associated with early elective cesarean sections: Survey

Results of a national survey point to a greater need to educate women on the risks associated with early elective cesarean sections and labor inductions.

19 Mar 2010

Clarient's Ovotax test may help improve patients’ response to taxane therapy

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent.

17 Mar 2010

TomTec's multi-modality cardiovascular image analysis technology to be delivered as part of Kardia Complete

Kardia Health Systems and TomTec Imaging Systems today announced a new partnership to deliver TomTec's multi-modality cardiovascular image analysis technology as a part of Kardia Complete™, Kardia's forthcoming Web-based service to simplify workflow and save time in cardiology practices.

17 Mar 2010

Acetaminophen safe and effective for reducing postpartum pain

For many mothers of newborns, lingering pain from the delivery can interfere with their first days with their infant. A recent review examined whether over-the-counter medications containing acetaminophen - Tylenol for example − provided adequate relief for such pain and concluded that they are effective.

17 Mar 2010

Human amniotic fluid skin cells "reprogrammed" to pluripotency

In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.

16 Mar 2010

Obstetrics News and Research

Further Reading

Two pioneering hospital systems to pilot Unity Medical's Medical Video jLog for Apple iPad

NPCs as effective as doctors in performing Caesarean sections

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

SEE BABY opens spa-like facility in mid-town Atlanta to provide low-cost medical care

Study evaluates OCP treatment to prevent endometrioma recurrence

Facts and treatment options for endometriosis

ASA encourages spreading awareness about Doctors Day 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Evaluating potential of Ampligen and TLR3 agonists as cancer immunotherapeutics

New CONSORT statement to improve reporting of trial findings published

Pregnant breast cancer patients can receive chemotherapy without endangering baby health

Clinicians can help pregnant women in making lifestyle changes for healthy weight gain

New provision in health care bill ensures physicians’ participation in PQRI program

HPV test could help predict risk of cervical cancer, but more research needed

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Women need education on risks associated with early elective cesarean sections: Survey

Clarient's Ovotax test may help improve patients’ response to taxane therapy

TomTec's multi-modality cardiovascular image analysis technology to be delivered as part of Kardia Complete

Acetaminophen safe and effective for reducing postpartum pain

Human amniotic fluid skin cells "reprogrammed" to pluripotency

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News